抗心律障碍药物的心律障碍和副作用
Paul Y Lee1, Juan Bello2, Hirad Yarmohammadi3
1Northwell Cardiovascular Institute, Northshore University Hospital, New Hyde Park, NY, USA.
Cardiac electrophysiology clinics
|January 29, 2026
概括
抗心律不整的药物对于治疗心律不整至关重要,但可以矛盾地引起它们. 本综述详细介绍了四种主要抗心律失常药物类别的不良影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 临床治疗学 临床治疗学
背景情况:
- 抗心律失常药物是治疗心律失常症的基础.
- 所有药物,包括抗节律障碍药物,都有潜在的副作用,需要仔细考虑.
- 尽管有其预期的功能,抗心律失常药可以矛盾地诱导心律失常.
研究的目的:
- 审查和突出与四大类抗心律失常药物相关的不良影响.
- 通过详细说明其潜在的危害,为临床决策提供有关抗节律障碍药物的使用的信息.
主要方法:
- 文献综述侧重于抗心律失常药物类别.
- 分析已记录的不良反应和矛盾的前节律事件.
- 综合有关作用机制和相关风险的信息.
主要成果:
- 四种主要类型的抗节律失常药,虽然在机制上有所不同,但它们都有可能引起心律失常.
- 具体的不良影响与每个类别相关,影响患者的安全.
- 了解这些风险对于适当的治疗应用至关重要.
结论:
- 临床医生必须仔细平衡抗心律失常药的益处与它们可能导致严重不良事件的潜在影响,包括心律失常.
- 对于安全的处方来说,意识到抗节律药物的矛盾的前节律效应是必不可少的.
- 需要进一步研究减轻这些不良影响.
相关概念视频
Inhaled Medications
795
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
795
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.6K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.6K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
3.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.0K
Endocarditis III: Medical Management
256
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
256
Myocarditis III: Medical Management
216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management
351
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
351


